The U.S. Food and Drug Administration has granted approval for a new drug targeting the mutations that drive more than 90% of ...
PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit discusses what she learned at the inaugural AACR Drug Discovery ...
The Pancreatic Cancer Action Network responds to FDA approval of Rasonque™ (daraxonrasib) for patients with previously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results